Merial, the animal health division of Sanofi-Aventis, broke ground on a $70 million expansion of its manufacturing facility in the Nanchang Hi-tech Development Zone. The existing factory, which has been in operation for almost 20 years, produces poultry vaccines for use in China. Phase I of the new construction will add almost 30,000 square meters of floor space, and the expansion will ultimately double the existing facility’s production capacity. More details...

Stock Symbol: (NYSE: SNY)